Meeting Banner
Abstract #0919

Hyaluronan depletion improved intratumor pO2 and sensitized tumor to radiation therapy in pancreatic cancer model mouse.

Yu Saida1, Tomohiro Seki2, Shun Kishimoto1, Yasunori Otowa1, Kota Yamashita1, Kazutoshi Yamamoto1, Nallathamby Devasahayam1, Jeffrey R. Brender1, and Murali C. Krishna1
1Radiation Biology Branch, National Cancer Institute, Bethesda, MD, United States, 2Laboratory of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan

PEGylated human hyaluronidase (PEGPH20) has been developed to enzymatically deplete tumor hyaluronan. The purpose of this study is to investigate physiologic and metabolic changes in pancreatic adenocarcinoma xenograft after PEGPH20 treatment by using multi-modal imaging and further determine the utility of PEGPH20 as radiosensitizer. PEGPH20 significantly increased intratumor pO2 and blood volume and decreased glycolytic flux assessed by EPRI, USPIO-MRI, and hyperpolarized 13C-MRI, respectively. PEGPH20 also enhanced treatment effect of radiotherapy in vivo. The results validated the utility of the imaging methods to non-invasively monitor changes in the tumor microenvironment and predicted the radiosensitizing effect upon hyaluronan depletion.

This abstract and the presentation materials are available to members only; a login is required.

Join Here